Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/5845
DC FieldValueLanguage
dc.contributor.authorDegenhardt, Louisaen_US
dc.contributor.authorGlantz, Meyeren_US
dc.contributor.authorEvans-Lacko, Saraen_US
dc.contributor.authorSadikova, Ekaterinaen_US
dc.contributor.authorSampson, Nancyen_US
dc.contributor.authorThornicroft, Grahamen_US
dc.contributor.authorAguilar-Gaxiola, Sergioen_US
dc.contributor.authorAl-Hamzawi, Alien_US
dc.contributor.authorAlonso, Jordien_US
dc.contributor.authorHelena Andrade, Lauraen_US
dc.contributor.authorBruffaerts, Ronnyen_US
dc.contributor.authorBunting, Brendanen_US
dc.contributor.authorBromet, Evelyn Jen_US
dc.contributor.authorMiguel Caldas de Almeida, Joséen_US
dc.contributor.authorde Girolamo, Giovannien_US
dc.contributor.authorFlorescu, Silviaen_US
dc.contributor.authorGureje, Oyeen_US
dc.contributor.authorMaria Haro, Josepen_US
dc.contributor.authorHuang, Yueqinen_US
dc.contributor.authorKaram, Aimeeen_US
dc.contributor.authorKaram, Elie Gen_US
dc.contributor.authorKiejna, Andrzejen_US
dc.contributor.authorLee, Singen_US
dc.contributor.authorLepine, Jean-Pierreen_US
dc.contributor.authorLevinson, Daphnaen_US
dc.contributor.authorElena Medina-Mora, Mariaen_US
dc.contributor.authorNakamura, Yosikazuen_US
dc.contributor.authorNavarro-Mateu, Fernandoen_US
dc.contributor.authorPennell, Beth-Ellenen_US
dc.contributor.authorPosada-Villa, Joséen_US
dc.contributor.authorScott, Kateen_US
dc.contributor.authorStein, Dan Jen_US
dc.contributor.authorTen Have, Margreeten_US
dc.contributor.authorTorres, Yolandaen_US
dc.contributor.authorZarkov, Zaharien_US
dc.contributor.authorChatterji, Somnathen_US
dc.contributor.authorKessler, Ronald Cen_US
dc.date.accessioned2022-06-29T09:50:56Z-
dc.date.available2022-06-29T09:50:56Z-
dc.date.issued2017-
dc.identifier.issn1723-8617-
dc.identifier.urihttps://scholarhub.balamand.edu.lb/handle/uob/5845-
dc.description.abstractSubstance use is a major cause of disability globally. This has been recognized in the recent United Nations Sustainable Development Goals (SDGs), in which treatment coverage for substance use disorders is identified as one of the indicators. There have been no estimates of this treatment coverage cross-nationally, making it difficult to know what is the baseline for that SDG target. Here we report data from the World Health Organization (WHO)'s World Mental Health Surveys (WMHS), based on representative community household surveys in 26 countries. We assessed the 12-month prevalence of substance use disorders (alcohol or drug abuse/dependence); the proportion of people with these disorders who were aware that they needed treatment and who wished to receive care; the proportion of those seeking care who received it; and the proportion of such treatment that met minimal standards for treatment quality ("minimally adequate treatment"). Among the 70,880 participants, 2.6% met 12-month criteria for substance use disorders; the prevalence was higher in upper-middle income (3.3%) than in high-income (2.6%) and low/lower-middle income (2.0%) countries. Overall, 39.1% of those with 12-month substance use disorders recognized a treatment need; this recognition was more common in high-income (43.1%) than in upper-middle (35.6%) and low/lower-middle income (31.5%) countries. Among those who recognized treatment need, 61.3% made at least one visit to a service provider, and 29.5% of the latter received minimally adequate treatment exposure (35.3% in high, 20.3% in upper-middle, and 8.6% in low/lower-middle income countries). Overall, only 7.1% of those with past-year substance use disorders received minimally adequate treatment: 10.3% in high income, 4.3% in upper-middle income and 1.0% in low/lower-middle income countries. These data suggest that only a small minority of people with substance use disorders receive even minimally adequate treatment. At least three barriers are involved: awareness/perceived treatment need, accessing treatment once a need is recognized, and compliance (on the part of both provider and client) to obtain adequate treatment. Various factors are likely to be involved in each of these three barriers, all of which need to be addressed to improve treatment coverage of substance use disorders. These data provide a baseline for the global monitoring of progress of treatment coverage for these disorders as an indicator within the SDGs.en_US
dc.language.isoengen_US
dc.publisherNational Library of Medicineen_US
dc.subjectSubstance use disordersen_US
dc.subjectUnited Nations Sustainable Development Goalsen_US
dc.subjectWorld Health Organizationen_US
dc.subjectAlcoholen_US
dc.subjectDrugsen_US
dc.subjectTreatment coverageen_US
dc.titleEstimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveysen_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1002/wps.20457-
dc.identifier.pmid28941090-
dc.identifier.scopus2-s2.0-85029725127-
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/85029725127-
dc.contributor.affiliationFaculty of Medicineen_US
dc.description.volume16en_US
dc.description.issue3en_US
dc.description.startpage299en_US
dc.description.endpage307en_US
dc.date.catalogued2022-06-29-
dc.description.statusPublisheden_US
dc.identifier.openURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608813/en_US
dc.relation.ispartoftextWorld Psychiatryen_US
dc.description.campusSGH campusen_US
Appears in Collections:Faculty of Medicine
Show simple item record

SCOPUSTM   
Citations

156
checked on Nov 23, 2024

Record view(s)

54
checked on Nov 22, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.